French pharma major Sanofi (Euronext: SAN) has gone big in its latest effort to address the perennial problem of how to speed up medical innovation.
The Paris-based company has teamed up with tech giant Google to establish a new virtual innovation lab with the ambition of transforming how future medicines and health services are delivered by tapping into the power of emerging data technologies.
Ameet Nathwani, chief digital officer, chief medical officer and executive vice president, medical at Sanofi, said: “We stand on the forefront of a new age for biology and human health, with the opportunity to transform healthcare through partnerships with pioneering technology and analytics companies.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze